Literature DB >> 3496603

Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.

S Zolla-Pazner, D C Des Jarlais, S R Friedman, T J Spira, M Marmor, R Holzman, D Mildvan, S Yancovitz, U Mathur-Wagh, J Garber.   

Abstract

Blood specimens from 165 intravenous drug users who were seropositive for the human immunodeficiency virus (HIV), from 158 seropositive homosexual men with lymphadenopathy, and from 77 patients with acquired immunodeficiency syndrome (AIDS) were assessed immunologically. Immunologic parameters were analyzed by the Guttman scalogram technique to determine if immunologic abnormalities occurred in a nonrandom pattern. The following four patterns emerged: (i) seropositivity for HIV with no immunologic abnormalities; (ii) seropositivity for HIV with a depressed T4/T8 cell ratio; (iii) seropositivity with a depressed T4/T8 cell ratio and T4-cell depletion; and (iv) seropositivity with a depressed T4/T8 cell ratio, T4-cell depletion, and lymphopenia. Ninety-two to 100% of subjects in each of the three groups of patients were found "to scale" because the abnormalities occurred in the cumulative, ordered fashion described. This nonrandom occurrence of abnormalities indicates an ordered progression of immunologic abnormalities in individuals infected with HIV, a finding useful in the staging of both symptomatic and asymptomatic HIV-seropositive subjects.

Entities:  

Mesh:

Year:  1987        PMID: 3496603      PMCID: PMC298864          DOI: 10.1073/pnas.84.15.5404

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Persistent increased immunoglobulin M in treated narcotic addition. Association with liver disease and continuing heroin use.

Authors:  P Cushman
Journal:  J Allergy Clin Immunol       Date:  1973-08       Impact factor: 10.793

Review 2.  The narcotic addict as a medical patient.

Authors:  J D Sapira
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

Review 3.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

4.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma.

Authors:  R E Stahl; A Friedman-Kien; R Dubin; M Marmor; S Zolla-Pazner
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

6.  Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.

Authors:  M De Waele; C Thielemans; B K Van Camp
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

7.  Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome.

Authors:  S Zolla-Pazner; D William; W El-Sadr; M Marmor; R Stahl
Journal:  JAMA       Date:  1984-06-08       Impact factor: 56.272

8.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.

Authors:  J J Goedert; R J Biggar; M Melbye; D L Mann; S Wilson; M H Gail; R J Grossman; R A DiGioia; W C Sanchez; S H Weiss
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

9.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  T cell subsets in patients with acute and chronic HBV infection, primary biliary cirrhosis and alcohol induced liver disease.

Authors:  H C Thomas
Journal:  Int J Immunopharmacol       Date:  1981
View more
  14 in total

1.  A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits.

Authors:  K Goodkin; D J Feaster; D Asthana; N T Blaney; M Kumar; T Baldewicz; R S Tuttle; K J Maher; M K Baum; P Shapshak; M A Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

2.  Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users.

Authors:  J B Page; S Lai; M A Fletcher; R Patarca; P C Smith; H C Lai; N G Klimas
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.

Authors:  J Laurence; S M Friedman; E K Chartash; M K Crow; D N Posnett
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

4.  Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.

Authors:  J Y Xu; M K Gorny; T Palker; S Karwowska; S Zolla-Pazner
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS.

Authors:  S J Gange; A Muñoz; J S Chmiel; A D Donnenberg; L M Kirstein; R Detels; J B Margolick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response.

Authors:  S Itescu; J Dalton; H Z Zhang; R Winchester
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

Authors:  M R Dawood; B Conway; P Patenaude; F Janmohamed; J S Montaner; M V O'Shaughnessy; G W Hammond
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

8.  Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.

Authors:  S C Kayman; Z Wu; K Revesz; H Chen; R Kopelman; A Pinter
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Generation of human monoclonal antibodies to human immunodeficiency virus.

Authors:  M K Gorny; V Gianakakos; S Sharpe; S Zolla-Pazner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value.

Authors:  M Levacher; F Hulstaert; S Tallet; S Ullery; J J Pocidalo; B A Bach
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.